BEAM Stock Summary and Trading Ideas (Beam Therapeutics | NASDAQ:BEAM)

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

Beam Therapeutics trades on the NASDAQ stock market under the symbol BEAM.

As of January 27, 2025, BEAM stock price declined to $25.91 with 760,458 million shares trading.

BEAM has a beta of 1.83, meaning it tends to be more sensitive to market movements. BEAM has a correlation of 0.12 to the broad based SPY ETF.

BEAM has a market cap of $2.15 billion. This is considered a Mid Cap stock.

Last quarter Beam Therapeutics reported $14 million in Revenue and -$1.17 earnings per share. This fell short of revenue expectation by $-231,000 and missed earnings estimates by -$.01.

In the last 3 years, BEAM traded as high as $80.00 and as low as $16.95.

The top ETF exchange traded funds that BEAM belongs to (by Net Assets): ARKK, VTI, IWM, VB, ARKG.

BEAM has underperformed the market in the last year with a price return of +6.7% while the SPY ETF gained +24.4%. However, in the short term, BEAM had mixed performance relative to the market. It has outperformed in the last 3 months, returning +20.2% vs +3.9% return in SPY. But in the last 2 weeks, BEAM shares have been beat by the market, returning +1.4% compared to an SPY return of +3.1%.

BEAM support price is $24.71 and resistance is $27.25 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BEAM shares will trade within this expected range on the day.